AR065410A1 - Disolucion solida amorfa que contiene un derivado de pirazol-3-carboxamida en forma amorfa y excipientes estabilizadores - Google Patents

Disolucion solida amorfa que contiene un derivado de pirazol-3-carboxamida en forma amorfa y excipientes estabilizadores

Info

Publication number
AR065410A1
AR065410A1 ARP080100705A ARP080100705A AR065410A1 AR 065410 A1 AR065410 A1 AR 065410A1 AR P080100705 A ARP080100705 A AR P080100705A AR P080100705 A ARP080100705 A AR P080100705A AR 065410 A1 AR065410 A1 AR 065410A1
Authority
AR
Argentina
Prior art keywords
carboxamide
derivative
amorphy
amorfa
pirazol
Prior art date
Application number
ARP080100705A
Other languages
English (en)
Inventor
Jean Alie
Michel Bauer
Jerome Menegotto
Original Assignee
Sawyers Charles L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sawyers Charles L filed Critical Sawyers Charles L
Publication of AR065410A1 publication Critical patent/AR065410A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Reivindicacion 1: Derivado de pirazol-3-carboxamida en forma amorfa, elegido entre la N-piperidin-5-(4-bromofenil)-1-(2,4-diclorofenil)-4-etilpirazol-3-carboxamida y la N-piperidin-5-(4-clorofenil)-1-(2,4-diclorofenil)-1-(2,4-diclorofenil)-4-metilpirazol-3-carboxamida. Composiciones farmacéuticas que lo contienen.
ARP080100705A 2007-02-23 2008-02-21 Disolucion solida amorfa que contiene un derivado de pirazol-3-carboxamida en forma amorfa y excipientes estabilizadores AR065410A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0701377A FR2913018A1 (fr) 2007-02-23 2007-02-23 Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs

Publications (1)

Publication Number Publication Date
AR065410A1 true AR065410A1 (es) 2009-06-03

Family

ID=38561793

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100705A AR065410A1 (es) 2007-02-23 2008-02-21 Disolucion solida amorfa que contiene un derivado de pirazol-3-carboxamida en forma amorfa y excipientes estabilizadores

Country Status (20)

Country Link
US (1) US20100076023A1 (es)
EP (1) EP2132182A2 (es)
JP (1) JP2010519246A (es)
KR (1) KR20090113305A (es)
CN (1) CN101641333A (es)
AR (1) AR065410A1 (es)
AU (1) AU2008240507A1 (es)
BR (1) BRPI0807575A2 (es)
CA (1) CA2678801A1 (es)
CL (1) CL2008000550A1 (es)
CO (1) CO6210812A2 (es)
EA (1) EA200970792A1 (es)
FR (1) FR2913018A1 (es)
IL (1) IL200370A0 (es)
MA (1) MA31244B1 (es)
MX (1) MX2009008991A (es)
PE (1) PE20081778A1 (es)
TW (1) TW200846339A (es)
UY (1) UY30937A1 (es)
WO (1) WO2008129157A2 (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2761266B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
FR2873372B1 (fr) * 2004-07-22 2006-09-08 Sanofi Synthelabo Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide
EP1844017A1 (en) * 2005-01-06 2007-10-17 Cadila Healthcare Ltd. An amorphous and three crystalline forms of rimonabant hydrochloride
AR052660A1 (es) * 2005-01-21 2007-03-28 Astex Therapeutics Ltd Derivados de pirazol para inhibir la cdk's y gsk's
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
EP1816125A1 (en) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
WO2007103711A2 (en) * 2006-03-01 2007-09-13 Dr. Reddy's Laboratories Ltd. Polymorphic forms of rimonabant
US8431609B2 (en) * 2007-02-19 2013-04-30 Darmesh Mahendrabhai Shah Process for preparation of pyrazole derivatives

Also Published As

Publication number Publication date
BRPI0807575A2 (pt) 2014-07-01
MA31244B1 (fr) 2010-03-01
TW200846339A (en) 2008-12-01
IL200370A0 (en) 2010-04-29
JP2010519246A (ja) 2010-06-03
WO2008129157A2 (fr) 2008-10-30
AU2008240507A1 (en) 2008-10-30
PE20081778A1 (es) 2009-01-01
FR2913018A1 (fr) 2008-08-29
CA2678801A1 (fr) 2008-10-30
CN101641333A (zh) 2010-02-03
UY30937A1 (es) 2008-09-30
EA200970792A1 (ru) 2010-04-30
CO6210812A2 (es) 2010-10-20
MX2009008991A (es) 2009-09-03
KR20090113305A (ko) 2009-10-29
CL2008000550A1 (es) 2008-07-04
EP2132182A2 (fr) 2009-12-16
US20100076023A1 (en) 2010-03-25
WO2008129157A3 (fr) 2008-12-31
WO2008129157A4 (fr) 2009-03-05

Similar Documents

Publication Publication Date Title
PE20071184A1 (es) Compuestos de aminoisoindolina para el tratamiento del lupus cutaneo
DK1863812T3 (da) Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler
AR065096A1 (es) Preparacion solida
CO6382116A2 (es) Composiciones que comprenden un arilpirazol y/o una formamidina, métodos y usos de las mismas
CR8767A (es) Indazoles sustituidos, composiciones que los contienen, procedimiento de preparacion y su uso
DK1881985T3 (da) Vandfrie krystalliske former af N-Y1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-D]pyrimidin-3-carbonyl¨methansulfonamid
CL2011002781A1 (es) Compuestos (e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol y (r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol; composicion farmaceutica que los comprende; y uso en el tratamiento del cancer.
CL2009000906A1 (es) Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
CL2008000279A1 (es) Composicion farmaceutica solida que comprende una parte que comprende 2-((6-(3r)-3-amino-1-piperidinil)3,4-dihidro-3-metil-2,4-dioxo-1-(2h)-pirimidin)metil)benzonitrilo, azucar o alcohol de azucar y una segunda parte que comprende pioglitazona y azuc
TW200800967A (en) Benzimidazole thiophene compounds
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
PA8691901A1 (es) Composicion farmaceutica solida que comprende 1-(4-cloro-anilino)-4-(4-piridil-metil)-ftalazina y un modificador del ph
ECSP066481A (es) Formulaciones que contienen cobre
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
CL2008001573A1 (es) Combinaciones fungicidas que contienen n-[2-(1,3-dimetilbutil)fenil]-5-fluoro-1,3-dimetil-1h-pirazol-4-carboxamida, al menos una acilalanina y al menos un derivado de estrobirulina; agentes que las comprenden; procedimiento para combatir hongos fitopatogenos en fitoproteccion; y uso de las combinaciones.
ECSP099386A (es) Agentes para combatir parásitos en animales
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
BR122016006880B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
DK1921918T3 (da) Koncentreret flydende triazolfungicidformuleringer
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
AR065410A1 (es) Disolucion solida amorfa que contiene un derivado de pirazol-3-carboxamida en forma amorfa y excipientes estabilizadores
TR201803451T4 (tr) Olmesartan formülasyonlari.
GT200700014A (es) Monohidrato de rimonabant, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen
MX2017008078A (es) Composiciones de (s)-n-(3-(6-isopropoxipiridin-3-il)-1h-indazol-5- il)-1-(2-(4-(4-(1-metil-1h-1,2,4-triazol-3-il)fenil)-3,6-dihidrop iridin-1(2h)-il)-2-oxoetil)-3-(metiltio)pirrolidin-3-carboxamida para preparaciones farmaceuticas.
MX2008010233A (es) Composicion de liberacion modificada, que comprende doxofilina.

Legal Events

Date Code Title Description
FB Suspension of granting procedure